Free Trial
NASDAQ:SBFMW

Sunshine Biopharma (SBFMW) Stock Price, News & Analysis

Sunshine Biopharma logo
$0.19 -0.06 (-24.25%)
As of 03:58 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Sunshine Biopharma Stock (NASDAQ:SBFMW)

Key Stats

Today's Range
$0.13
$0.32
50-Day Range
$0.14
$0.80
52-Week Range
$0.04
$0.98
Volume
19,080 shs
Average Volume
18,665 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is headquartered in New York, New York.

Remove Ads
Receive SBFMW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sunshine Biopharma and its competitors with MarketBeat's FREE daily newsletter.

SBFMW Stock News Headlines

Sunshine Biopharma reports FY24 revenue $34.9M vs $24.1M last year
Sunshine Biopharma announces results from studies on K1.1-mRNA-LNP product
Three new patents reveal Elon and Trump’s secret “Project America”
Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR! He says these 5 stocks are trading for less than $2 right now… But they could soon SOAR in Trump’s first 100 days.
Sunshine Biopharma announces research results on K1.1 mRNA product
See More Headlines

SBFMW Stock Analysis - Frequently Asked Questions

Sunshine Biopharma's stock was trading at $0.1609 at the beginning of the year. Since then, SBFMW shares have increased by 17.5% and is now trading at $0.1890.
View the best growth stocks for 2025 here
.

Shares of SBFMW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SBFMW
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$32.96 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:SBFMW) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners